Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMO: CSF Analysis for HIV+ Cognitive Symptoms
NCT02144688Phase 1Terminated
- Start
- Jun 2011
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in human immunodeficiency virus infection (HIV). Primary endpoint: Changes in neurocognitive functioning over 6 months. Started Jun 2011; status: terminated.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02144688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144688.